BWH Vaccine Trials Unit's Avatar

BWH Vaccine Trials Unit

@bwhvax.bsky.social

We are a Boston-based research and community engagement group focused on raising awareness about infectious disease vaccines and supporting HIV and other vaccine research locally, nationally, and globally.

10 Followers  |  58 Following  |  3 Posts  |  Joined: 10.11.2025  |  1.5211

Latest posts by bwhvax.bsky.social on Bluesky

Preview
Dr. Whitney Irie on PrEP Use and Black Women in the Deep South - AIDSVu

Yesterday, 2/7, was National Black HIV/AIDS Awareness Day (NBHAAD). To celebrate Black History month, we would like to share an @aidsvu interview from Dr. Whitney Irie on HIV prevention and stigma affecting Black women.

aidsvu.org/news-updates...

08.02.2026 21:17 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Preview
National Black HIV/AIDS Awareness Day: Advancing health equity through collaborative care Collaborative care models offer a proven blueprint for improving outcomes among Black Americans with HIV.

Tomorrow, February 7th, is National Black HIV/AIDS Awareness Day which draws our attention to the importance of dismantling the structural barriers that lead to these inequities.

For more information about this, check out this article from @idsainfo.bsky.social: www.idsociety.org/science-spea....

06.02.2026 16:25 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Preview
Safety and immunogenicity of PanChol, a single-dose live-attenuated oral cholera vaccine: results from a phase 1a, double-blind, randomised, placebo-controlled trial A single oral dose of PanChol was safe and well tolerated at all doses and induced 100% vibriocidal seroconversion over a 100 000-fold dose range. These findings support the progression of PanChol int...

Mass General Brigham–developed cholera vaccine completes phase 1 trial

Clinical trial shows promising results for PanChol, a single-dose oral vaccine aimed at the up to 4 million annual cholera cases worldwide

www.thelancet.com/journals/lan...

08.01.2026 01:48 β€” πŸ‘ 4    πŸ” 2    πŸ’¬ 0    πŸ“Œ 0
Preview
Safety and immunogenicity of PanChol, a single-dose live-attenuated oral cholera vaccine: results from a phase 1a, double-blind, randomised, placebo-controlled trial A single oral dose of PanChol was safe and well tolerated at all doses and induced 100% vibriocidal seroconversion over a 100 000-fold dose range. These findings support the progression of PanChol int...

New Research:

Safety and immunogenicity of PanChol, a single-dose live-attenuated oral cholera vaccine: results from a phase 1a, double-blind, randomised, placebo-controlled trial

www.thelancet.com/journals/lan...

08.01.2026 08:01 β€” πŸ‘ 1    πŸ” 2    πŸ’¬ 0    πŸ“Œ 0
Preview
Safety and immunogenicity of PanChol, a single-dose live-attenuated oral cholera vaccine: results from a phase 1a, double-blind, randomized, placebo-controlled trial Background Current whole-cell killed oral cholera vaccines have utility but require multiple doses and have limited efficacy in young children. PanChol is a single-dose live-attenuated cholera vaccine...

Phase Ia study of a single dose oral cholera vaccine…

Per authors: β€œA single oral dose of PanChol induced 100% vibriocidal seroconversion over a 100,000-fold dose range with no safety concerns”

www.medrxiv.org/content/10.1... #IDSky

08.01.2026 14:17 β€” πŸ‘ 0    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Mass General Brigham–Developed Cholera Vaccine Completes Phase 1 Trial | Mass General Brigham A team of scientists and physicians at Mass General Brigham has developed PanChol, a single-dose oral cholera vaccine, and completed testing in a phase 1 clinical trial with promising results.

We are excited to share the results from a Phase 1a trial we conducted testing the safety and immunogenicity of PanChol, a live-attenuated oral cholera vaccine.

Press release here: www.massgeneralbrigham.org/en/about/new...
Full text article link: www.thelancet.com/journals/lan...

08.01.2026 15:57 β€” πŸ‘ 1    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0

@bwhvax is following 20 prominent accounts